|
⚲
|
| Keyboard |
| Exagen Inc | |
|---|---|
| Ticker | XGN |
| CIK # | 0001274737 |
| CUSIP | 30068X103 |
| Sector | Life Sciences - Services-Medical Laboratories |
| Address | 1261 Liberty Way, Vista, CA 92081 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Exagen Inc | 2019-02-01 | 6.6 M | Exemption: 506(b) · Remaining: $9,413,589 · Duration: One year or less · Revenue: Decline to Disclose |
| Exagen Diagnostics Inc | 2017-05-18 | 3.7 M | Exemption: 506(b) · Remaining: $9,429,803 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001274737] | 10-K | |
| [0001274737] | 10-Q | |
| [0001274737] | 3 | |
| [0001274737] | 4 | |
| [0001274737] | 8-K | |
| [0001274737] | D | |
| [0001274737] | SC 13D | |
| [0001274737] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Parian Ultreia LP | Exagen Inc | [2026-05-27] | 0.0 |
| Chernett Jorey | Exagen Inc | [2026-02-04] | 0.0 |
| Lytton Laurence W | Exagen Inc | [2022-11-23] | 5.1 |
| Bank of Montreal /Can/ | Exagen Inc | [2022-02-15] | 6.3 |
| Stonepine Capital Management LLC | Exagen Inc | [2021-12-27] | 5.2 |
| Cowen Financial Products LLC | Exagen Inc | [2021-12-17] | 5.41 |
| HIG Bio-Exagen LP | Exagen Inc | [2021-02-24] | 13.4 |
| Wasatch Advisors Inc | Exagen Inc | [2021-02-11] | 8.3 |
| NMSIC Co-Investment Fund LP | Exagen Inc | [2020-09-18] | 19.26 |
| Tullis Dickerson Capital Focus III LP | Exagen Inc | [2020-02-14] | 0.7 |
| Hunt Holdings Limited Partnership | Exagen Inc | [2020-02-07] | 11.8 |
| RTW Investments LP | Exagen Inc | [2020-01-27] | 7.18 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aballi John
Stock Option(right to buy) · derivative
|
2026-03-12 | Grant | 100,000 | $3.16 | 316,000 |
|
Black Jeffrey G
Common Stock
|
2026-03-12 | Grant | 75,000 | $3.16 | 237,000 |
|
Aballi John
Common Stock
|
2026-03-12 | Grant | 150,000 | $0.00 | |
|
Black Jeffrey G
Stock Option(right to buy) · derivative
|
2026-03-12 | Grant | 50,000 | $3.16 | 158,000 |
|
Aballi John
Common Stock
|
2026-03-03 | Grant | 2,535 | $3.08 | 7,808 |
|
Aballi John
Common Stock
|
2026-03-03 | Sell | 15,698 | $3.62 | 56,827 |
|
Black Jeffrey G
Common Stock
|
2026-02-27 | Grant | 1,511 | $3.08 | 4,654 |
|
Aballi John
Common Stock
|
2026-02-24 | Sell | 11,430 | $3.61 | 41,262 |
|
Black Jeffrey G
Common Stock
|
2026-02-24 | Sell | 1,584 | $3.61 | 5,718 |
|
Aballi John
Common Stock
|
2025-10-16 | Sell | 31,787 | $11.82 | 375,722 |
|
Common Stock
|
2025-09-02 | Sell | 20,466 | $9.79 | 200,362 |
|
Kim Paul
Stock Option(right to buy) · derivative
|
2025-06-10 | Grant | 9,000 | $0.00 | |
|
Stock Option(right to buy) · derivative
|
2025-06-10 | Grant | 9,000 | $0.00 | |
|
Stokes Frank
Stock Option(right to buy) · derivative
|
2025-06-10 | Grant | 9,000 | $0.00 | |
|
Kahn Scott D
Stock Option(right to buy) · derivative
|
2025-06-10 | Grant | 9,000 | $0.00 | |
|
Hooker Ana
Stock Option(right to buy) · derivative
|
2025-06-10 | Grant | 9,000 | $0.00 | |
|
Nova Tina Susan
Stock Option(right to buy) · derivative
|
2025-06-10 | Grant | 13,500 | $0.00 | |
|
NMSIC Co-Investment Fund LP +1
Common Stock
|
2025-03-25 | Sell | 350,000 | $3.30 | 1,155,000 |
|
Aballi John
Common Stock
|
2025-02-28 | Grant | 8,621 | $2.47 | 21,294 |
|
Black Jeffrey G
Common Stock
|
2025-02-21 | Grant | 15,000 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 61 | 8,984,113 |
| 2025-12-31 | 80 | 10,365,880 |
| 2025-09-30 | 62 | 9,093,139 |
| 2025-06-30 | 54 | 9,206,880 |
| 2025-03-31 | 39 | 6,258,797 |
| 2024-12-31 | 42 | 6,120,624 |
| 2024-09-30 | 34 | 6,387,072 |
| 2024-06-30 | 34 | 6,347,674 |
| 2024-03-31 | 32 | 7,175,416 |
| 2023-12-31 | 31 | 7,175,182 |
| 2023-09-30 | 30 | 6,865,400 |
| 2023-06-30 | 29 | 6,882,688 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares | Prev | Page 1 | Next |